TWiV 758: COVID-19 clinical update #63 with Dr. Daniel Griffin
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In COVID-19 clinical update #63, Daniel Griffin reviews cases at child care facilities, estimates of mRNA vaccine effectiveness, risk of reinfection in university students, enhanced antibody generation with extended interval of mRNA vaccination, no benefit of convalescent plasma in hospitalized patients, and risk of clinical sequelae after acute infection.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- COVID-19 in child care facilities (MMWR)
- mRNA vaccine effectiveness (MMWR)
- Excelsior pass (NYS)
- Risk of SARS-CoV-2 reinfection in university students (CID)
- Enhanced antibody production with longer mRNA vaccine interval (medRxiv)
- Convalescent plasma trial in hospitalized patients (Lancet)
- Phase 3 data on REGEN-COV (PR Newswire)
- Clinical sequelae after acute COVID-19 (BMJ)
- Letters read on TWiV 758
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]